Editas Medicine Stock Forecast

Stock Price Forecast

The 10 analysts that cover Editas Medicine stock have a consensus rating of "Buy" and an average price target of $5.40, which forecasts a 100.74% increase in the stock price over the next year. The lowest target is $3.00 and the highest is $13.

Price Target: $5.40 (+100.74%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$3.00	$5.40	$5.00	$13
Change	+11.52%	+100.74%	+85.87%	+383.27%

Analyst Ratings

The average analyst rating for Editas Medicine stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Apr '25	May '25	Jun '25	Jul '25	Aug '25	Sep '25
Strong Buy	5	4	4	4	4	4
Buy	2	2	2	2	2	2
Hold	7	6	6	6	5	5
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	15	13	13	13	12	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mitchell S. Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $5	Strong Buy	Reiterates	$5	+85.87%	Sep 5, 2025
Yanan Zhu Wells Fargo	Wells Fargo	Hold Maintains $3 → $4	Hold	Maintains	$3 → $4	+48.70%	Sep 3, 2025
Mitchell S. Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $3 → $5	Strong Buy	Maintains	$3 → $5	+85.87%	Aug 15, 2025
Joel Beatty Baird	Baird	Buy Maintains $4 → $6	Buy	Maintains	$4 → $6	+123.05%	Aug 13, 2025
Joel Beatty Baird	Baird	Buy Maintains $8 → $4	Buy	Maintains	$8 → $4	+48.70%	May 13, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

17.67M

from 32.31M

-45.33%

from 32.31M

Revenue Next Year

12.22M

from 17.67M

-30.81%

from 17.67M

EPS This Year

-2.10

from -2.88

EPS Next Year

-1.08

from -2.10

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	90.73M	25.54M	19.71M	78.12M	32.31M	17.67M	12.22M
Revenue Growth	341.93%	-71.85%	-22.83%	296.32%	-58.64%	-45.33%	-30.81%
EPS	-1.98	-2.85	-3.21	-2.02	-2.88	-2.10	-1.08
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	15	15

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	34.9M	26.6M
Avg	17.7M	12.2M
Low	9.1M	n/a

Revenue Growth

Revenue Growth	2025	2026
High	7.9%	50.7%
Avg	-45.3%	-30.8%
Low	-72.0%	-

EPS Forecast

EPS	2025	2026
High	-1.97	-0.66
Avg	-2.10	-1.08
Low	-2.18	-1.35

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.